2026年4月27日 作者 hycellbio 0

Target, Block, Clear – Next-Generation Topical Solution for HPV Management






Anti-HPV Bioprotein Dressing | Mojini




🛡️
Anti-HPV Bioprotein Dressing

Mojini / TUIJINI
✔ Class II Medical Device
Reg.No.
鄂械注准2025185909
📄 Production License: 鄂药监械生产许20231235号  |  
⚕️ For localized HPV viral load reduction & cervical protection

🧪 Core mechanism

⚡ Acidified bovine β-lactoglobulin
Derived from milk protein → surface negative charges. Binds to HPV capsid (L1/L2 positive regions), inactivates virus and blocks cell entry.

🎯 Result: HPV loses infectivity, viral load decreased locally.

💧 Carbomer + Triethanolamine → reduces bacteria, covers damaged mucosa, supports healing, and helps eliminate inactivated virus.

🔬
Selective targeting

Negative charges attract HPV virions → physical blocking, no systemic absorption. Safe & non-toxic.

🦠 ➡️ 🛡️ ➡️ ✅

HPV virus → Bioprotein binding → Inactivation & clearance

1. Recognition – Negative charges attract HPV particles
2. Blockade – Prevents HPV entry into basal cells
3. Barrier & repair – Protects erosive tissue, reduces inflammation
⭐ Destroys viral infectivity · Rapid turnover · Reduces HPV DNA load

📖 What is HPV? & Why intervene?

HPV (human papillomavirus) — over 120 subtypes. High-risk types (16,18,31,33,45,52,58…) cause 99.7% of cervical cancer. Persistent infection → cervical lesions (CIN1→CIN3).

⚠️ Key threat: HPV can lead to cervical intraepithelial neoplasia, genital warts, and increase infertility risk.

✔ Surgical excision (LEEP) removes lesions but residual virus persists → recurrence risk. That’s why adjuvant antiviral dressing is crucial.

⚠️🩺
High-risk HPV
16·18·31·33·35·39·45·51·52·56·58·59·68
Cervical cancer driver
🔄 HPV Infection process
Asymptomatic

Persistent infection

Dysplasia (CIN1/2/3)

Cancer

High-risk groups: Multiple partners · Immunocompromised · Prior HPV history · Improper hygiene (underwear mixed washing).

💡 The dressing aims to block at “infection” or “persistent infection” stage → prevent progression.

👥

HPV susceptible population
✔ Immunodeficiency
✔ Multiple sexual partners
✔ History of HPV infection
✔ Unprotected exposure
Anti-HPV dressing →
Interrupts virus replication cycle

🎯

Indicated for HPV+ individuals & prevention

  • ✅ Local reduction of HPV viral load (high-risk & low-risk types)
  • ✅ Post-surgical (conization/LEEP) or post-wart excision to reduce recurrence
  • ✅ Cutaneous HPV-related lesions: condyloma acuminatum, verruca plana, common warts
  • ✅ For both male and female genital tract infections

🔬 Acidified bovine β‑lactoglobulin — scientific breakthrough

🛡️
Step 1 · Viral inactivation

Negative charges bind HPV L1/L2 capsid regions -> irreversible structural change. Virus loses ability to infect cells.

🚫
Step 2 · Block entry

Prevents HPV from attaching to basement membrane receptors. No intracellular penetration, stops continuous infection.

🩹
Step 3 · Vaginal barrier & repair

Carbomer + triethanolamine cover erosive tissue, restore pH, promote healing, obstruct reinfection.

🧪🔁 Clinical perspective: Acidified β‑lactoglobulin acts extracellularly, does NOT enter human cells or circulation → excellent safety profile. Used as adjunctive therapy to accelerate HPV negative conversion.
📌⚠️ Evidence-based note & medical advice
• As a Class II Medical Device, it works via physical blocking, not a direct cure. It should be used under professional guidance.
• Does not replace HPV vaccination nor routine cervical screening (Pap smear / HPV DNA test).
• Most HPV infections (80%) clear spontaneously within 1–2 years. This dressing supports immune system by lowering viral burden.
• Milk protein allergy: caution due to β‑lactoglobulin derivative.
💧 3g x 5 applicators
intravaginal/cutaneous use
🌿 pH regulating
unfavorable for HPV survival
✅ Macrophage activity
local immune modulation
✨ Break the chain · Lower HPV load · Support rapid negative conversion ✨

Medical Device Registration: 鄂械注准2025185909 | Production license: 鄂药监械生产许20231235号 | Mojini Anti-HPV Bioprotein Dressing
Always consult healthcare provider before use. This content is an English informational summary.